Swiss-based Basilea Pharmaceutical’s antimicrobial drug gets FDA nod
HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and
HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and
HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian
HQ Team April 3, 2024: The deaths of about 100,000 cattle in India, which started two years ago, have been tracked to a
HQ Team April 3, 2024: A smartphone can measure the glucose levels of diabetic patients, diagnose disease and detect environmental toxins, with the
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
HQ Team April 1, 2024: The surge in neurological and neurodevelopmental conditions over the past decade has raised concerns among medical experts, who
HQ Team April 1, 2024: Preventing the spread of sexually transmitted infections (STIs) might soon be as simple as taking a couple of
HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering